Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Netskope Inc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2026
FY2026
Revenue
407
538
709
Cost of revenue
164
190
226
Gross profit
243
348
483
Research and development
224
254
509
Selling and marketing
263
281
394
General and administrative
68.5
68.6
232
Operating income
-313
-256
-653
Other non-operating income
13.3
4.1
18.8
Pre-tax income
-338
-350
-668
Income tax
6.78
4.24
11.3
Net income
-345
-355
-679
EBITDA
-263
-204
-607
EPS, basic
-3.77
-3.64
-3.18
EPS, diluted
-3.77
-3.64
-3.18
Shares, basic (weighted)
91.4
97.5
214
Shares, diluted (weighted)
91.4
97.5
214
Balance sheet
FY2024
FY2026
FY2026
Cash and equivalents
166
433
Short-term investments
80.7
726
Receivables
195
158
Inventory
5.76
4.9
Other current assets
38
73.6
Total current assets
528
1,449
Property, plant and equipment
99.5
93.9
Lease right-of-use assets
34.6
32.1
Goodwill
57.2
61.1
61.1
Intangible assets
37.2
21.4
Other non-current assets
18.9
14.1
Total assets
859
1,772
Accounts payable
2.65
14.4
Accrued liabilities
62.8
99.9
Deferred revenue
430
533
Total current liabilities
527
682
Lease liabilities
25.8
23.4
Other non-current liabilities
4.81
8.72
Total liabilities
1,344
1,578
Paid-in capital
419
2,888
Retained earnings
-1,950
-2,629
Other comprehensive income
-5.44
-64.8
Shareholders' equity
-257
-486
195
Total equity
-257
-486
195
Total liabilities and equity
859
1,772
Cash flow statement
FY2024
FY2026
FY2026
Net income
-345
-355
-679
Depreciation and amortization
49.5
51.5
45.9
Stock-based compensation
61
50.8
516
Deferred income tax
-2.45
-3.37
-2.26
Change in receivables
-8.19
-81.1
36.8
Change in inventory
-5.6
0.69
0.53
Change in payables
-7.04
-4.09
11.4
Cash from operations
-167
-111
38.1
Capital expenditures
-30.6
-33.7
-22.9
Acquisitions
-13.6
-2.51
0
Purchases of investments
-133
-104
-806
Sales and maturities of investments
0.99
0
80.5
Cash from investing
177
2.24
-667
Debt issued
0
74.4
0
Stock issued
10.2
35.6
35.3
Share buybacks
0
0
-0.57
Cash from financing
6.29
110
895
Net change in cash
16.1
1.43
267
Free cash flow
-198
-144
15.2
Interest paid
0
0.01
0
Income taxes paid
7.9
6.63
10.6
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $17.67 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
69.9%
Gross profit / revenue.
Operating margin
-94.7%
Operating income / revenue.
EBITDA margin
-90.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Net margin
-91.8%
Net income / revenue.
FCF margin
-8.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-5.1%
Cash from operations / revenue.
Return on equity (ROE)
-470.2%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-43.1%
Net income / average total assets.
R&D / revenue
71.7%
Research and development expense / revenue.
Stock-based pay / revenue
79.4%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
3.6%
Capital expenditures / revenue.
D&A / revenue
4.4%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
31.7%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
38.7%
Gross profit vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
106.4%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
119.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.01x
Current assets / current liabilities.
Quick ratio
1.82x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.55x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.82
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.98
Revenue / diluted weighted shares.
FCF per share
-$0.17
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.10
Cash from operations / diluted weighted shares.
Book value per share
$0.39
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
8.89x
Market cap / revenue.
P/B
45.5x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
92.5x
Market cap / tangible book value, when positive.
EV/Sales
7.56x
Enterprise value / revenue.
FCF yield
-1.0%
Free cash flow / market cap.
Earnings yield
-10.3%
Net income / market cap (the inverse of P/E).
What was Netskope Inc's revenue in fiscal 2026?
Netskope Inc reported revenue of $709.0M for fiscal 2026, 31.7% higher than the year before.
Was Netskope Inc profitable in fiscal 2026?
No. It reported a net loss of $679.4M.
How much free cash flow did Netskope Inc generate in fiscal 2026?
Cash from operations of $38.1M minus capital expenditures of $22.9M left free cash flow of $15.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.